Skip to main content
David Johnson, MD, Oncology, Scottsbluff, NE, Ascension Via Christi St. Francis

DavidBJohnsonMD

Oncology Scottsbluff, NE

Physician

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Johnson's full profile

Already have an account?

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1983 - 1986
  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1980 - 1983
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 1980

Certifications & Licensure

  • WY State Medical License
    WY State Medical License 1985 - 2024
  • KS State Medical License
    KS State Medical License 1988 - 2024
  • NE State Medical License
    NE State Medical License 2013 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • A Career in Lung Cancer: Pushing Beyond Chemotherapy 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

  • GigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to Anti-PD-L1 Therapies
    GigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to Anti-PD-L1 TherapiesMay 25th, 2021
  • Enveric Biosciences Buys MagicMed in All Stock Deal Valued at $30 Million
    Enveric Biosciences Buys MagicMed in All Stock Deal Valued at $30 MillionMay 24th, 2021
  • Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
    Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and DerivativesMay 24th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations